

Cover Story
Conversation with The Cancer LetterCOVID-19 & CancerFree
As he watches COVID-19 numbers climb in New Jersey, Steven K. Libutti reviews all the things he had learned last spring, when the pandemic first slammed the state.
In Brief
Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for Nov. 2020
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Dana-Farber/Harvard Cancer Center awarded $12M NIH SPORE grant to advance breast cancer research
- Sakaguchi, Ramsdell, Rudensky win Crafoord Prize for discoveries in immune regulation
- Anthony Letai sworn in as 18th NCI director
- Trump backs off the 100% pharma tariffs ultimatum
- U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs - The evolution of cellular immunotherapy: From transplant to CAR T cells